BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35561695)

  • 1. High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
    Tanji M; Mineharu Y; Sakata A; Okuchi S; Fushimi Y; Oishi M; Terada Y; Sano N; Yamao Y; Arakawa Y; Yoshida K; Miyamoto S
    J Neurosurg; 2023 Jan; 138(1):120-127. PubMed ID: 35561695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
    Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
    BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
    Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
    J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Brain Biopsy Hemorrhage Risk Factors and Implications for Postoperative Care at a Single Institution: An Argument For Postoperative Imaging.
    Barkley AS; Sullivan LT; Gibson AW; Camacho D; Barber JK; Ko AL; Silbergeld DL; Ravanpay AC
    World Neurosurg; 2020 Dec; 144():e807-e812. PubMed ID: 32956884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.
    Fahrendorf D; Hesselmann V; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Heindel W; Bink A
    J Neuroimaging; 2015; 25(6):1015-22. PubMed ID: 25703027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis.
    Chen J; Sun J; Xing W; Ding J; Chen T; Dai Y; Sun J; Hu J
    Acta Radiol; 2014 Apr; 55(3):378-84. PubMed ID: 23946232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study.
    Kim HS; Jahng GH; Ryu CW; Kim SY
    AJNR Am J Neuroradiol; 2009 Sep; 30(8):1574-9. PubMed ID: 19461062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
    Radbruch A; Wiestler B; Kramp L; Lutz K; Bäumer P; Weiler M; Roethke M; Sahm F; Schlemmer HP; Wick W; Heiland S; Bendszus M
    Eur J Radiol; 2013 Mar; 82(3):552-6. PubMed ID: 23238364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment intratumoral susceptibility signals correlate with response to high-dose methotrexate and progression-free survival in primary central nervous system lymphoma.
    Deguchi S; Nakashima K; Muramatsu K; Mitsuya K; Oishi T; Shirata K; Hayashi N; Sugino T; Endo M; Nakasu Y
    J Clin Neurosci; 2019 Nov; 69():43-50. PubMed ID: 31427235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
    Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
    Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of intratumoral micromorphology for patients with clear cell renal cell carcinoma using susceptibility-weighted imaging.
    Chen J; Ding J; Dai Y; Xing W; Sun J; Zhang Z; Xuan Y; Pilli V; Haacke EM; Hu J
    PLoS One; 2013; 8(6):e65866. PubMed ID: 23755287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
    Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
    Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of susceptibility-weighted imaging and intratumoral susceptibility signals in grading and differentiating pediatric brain tumors at 1.5 T: a preliminary study.
    Gaudino S; Marziali G; Pezzullo G; Guadalupi P; Giordano C; Infante A; Benenati M; Ramaglia A; Massimi L; Gessi M; Frassanito P; Caldarelli M; Colosimo C
    Neuroradiology; 2020 Jun; 62(6):705-713. PubMed ID: 32140783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging.
    Yang X; Xing Z; She D; Lin Y; Zhang H; Su Y; Cao D
    BMC Med Imaging; 2022 May; 22(1):105. PubMed ID: 35644621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.